SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+0.65%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$660M
AUM Growth
+$660M
(-9.7%)
Cap. Flow
-$73.1M
Cap. Flow
% of AUM
-11.08%
Top 10 Holdings %
Top 10 Hldgs %
49.85%
Holding
121
New
21
Increased
35
Reduced
19
Closed
35
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$18.8M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$11.7M |
| 3 |
Stoke Therapeutics
STOK
|
$9.72M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$9.39M |
| 5 |
Verint Systems
VRNT
|
$9.07M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$31.2M |
| 2 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
$27.7M |
| 3 |
Novo Nordisk
NVO
|
$20.9M |
| 4 |
Viatris
VTRS
|
$11.5M |
| 5 |
Novartis
NVS
|
$9.61M |
Sector Composition
| 1 | Healthcare | 77.74% |
| 2 | Technology | 12.98% |
| 3 | Industrials | 2.53% |
| 4 | Consumer Discretionary | 2.11% |
| 5 | Communication Services | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
AudioCodes
AUDC
$273M
| $7.06M | 0.97% | 456,222 +269,177 | +144% | +$4.17M |
|
|
MYOK
27
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $7.02M | 0.96% | 140,000 +27,000 | +24% | +$1.35M |
|
28
SPDR S&P Homebuilders ETF
XHB
$1.92B
| $6.95M | 0.95% | 166,796 +58,862 | +55% | +$2.45M |
|
29
Sarepta Therapeutics
SRPT
$1.78B
| $6.84M | 0.94% | 45,000 -28,405 | -39% | -$4.32M |
|
30
Aldeyra Therapeutics
ALDX
$351M
| $6.42M | 0.88% | 1,069,089 | – | – |
|
31
iShares 20+ Year Treasury Bond ETF
TLT
$47.8B
| $5.98M | 0.82% | 45,000 +15,000 | +50% | +$1.99M |
|
|
FSCT
32
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $5.85M | 0.8% | 172,846 +97,221 | +129% | +$3.29M |
|
33
Kornit Digital
KRNT
$669M
| $5.74M | 0.79% | 181,274 +119,870 | +195% | +$3.79M |
|
34
Palo Alto Networks
PANW
$127B
| $5.7M | 0.78% | 27,976 -2,778 | -9% | -$566K |
|
35
argenx
ARGX
$43.6B
| $5.46M | 0.75% | 38,581 +5,000 | +15% | +$708K |
|
36
Sutro Biopharma
STRO
$72.7M
| $5.07M | 0.69% | 445,889 +8,000 | +2% | +$91K |
|
|
DRNA
37
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $4.96M | 0.68% | +314,642 | New | +$4.96M |
|
38
Regenxbio
RGNX
$451M
| $4.91M | 0.67% | +95,564 | New | +$4.91M |
|
|
HARP
39
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $4.86M | 0.67% | 374,031 +43,231 | +13% | +$562K |
|
|
NEOS
40
DELISTED
Neos Therapeutics, Inc
NEOS
| $4.79M | 0.66% | 3,711,454 +1,509,757 | +69% | +$1.95M |
|
41
Allot
ALLT
$362M
| $4.77M | 0.65% | 661,031 -304,900 | -32% | -$2.2M |
|
42
Krystal Biotech
KRYS
$4.27B
| $4.74M | 0.65% | 117,625 -64,000 | -35% | -$2.58M |
|
43
uniQure
QURE
$896M
| $4.7M | 0.64% | 60,149 -17,200 | -22% | -$1.34M |
|
44
Rocket Pharmaceuticals
RCKT
$354M
| $4.65M | 0.64% | 310,000 +19,999 | +7% | +$300K |
|
45
Arvinas
ARVN
$568M
| $4.51M | 0.62% | 205,281 +7,228 | +4% | +$159K |
|
46
Precision BioSciences
DTIL
$57.8M
| $4.44M | 0.61% | 335,000 +110,000 | +49% | +$1.46M |
|
47
International Flavors & Fragrances
IFF
$17.3B
| $4.35M | 0.6% | +30,000 | New | +$4.35M |
|
48
Y-mAbs Therapeutics
YMAB
$388M
| $4.35M | 0.59% | +190,000 | New | +$4.35M |
|
49
ProQR Therapeutics
PRQR
$237M
| $4.28M | 0.59% | 470,000 +280,000 | +147% | +$2.55M |
|
50
Minerva Neurosciences
NERV
$16.5M
| $4.23M | 0.58% | 752,018 +110,000 | +17% | +$619K |
|